InvestorsHub Logo
Followers 2
Posts 429
Boards Moderated 0
Alias Born 07/13/2016

Re: wimike post# 29892

Thursday, 09/21/2017 10:38:08 AM

Thursday, September 21, 2017 10:38:08 AM

Post# of 38634
I think we need to resign ourselves to some level of dilution as it is inevitable if they are not able to raise capital from partnering their current drugs (or they just don't think that is the wisest use of capital). If (and I believe it is more likely a question of "when" rather than "if") they do sell additional shares we simply have to hope they tread as lightly as possible on long-suffering shareholders. Since the Odidi's are one of those long suffering shareholders, there is a better chance than normal that legacy shareholders will not get crushed in a new share offering. Also, if Rexista is not dead and they get some generics approved soon, the price of the stock should jump meaningfully, therby reducing the inevitable dilution.